INTEGER HOLDINGS CORPORATION
Registration details
Company overview
Integer Holdings Corporation is a Delaware corporation, registered with the Delaware Division of Corporations under file number 2761902, incorporated on 6 January 1998 and recorded as active. The company’s principal executive offices are at 5830 Granite Parkway, Suite 1150, Plano, Texas 75024, and its common stock trades on the New York Stock Exchange under the ticker symbol ITGR. Integer Holdings Corporation was previously named Greatbatch, Inc., a name it carried until 2016 following its 2015 merger with Lake Region Medical; SEC filings still reference the company’s historical “GB” EDGAR short name.
According to its Form 10-K filed with the SEC on 23 February 2026 for the fiscal year ended 31 December 2025, Integer Holdings Corporation is one of the world’s largest medical device contract development and manufacturing organizations (CDMOs). It designs and manufactures components, subassemblies and finished devices for three principal markets: Cardio & Vascular, Cardiac Rhythm Management, and Neuromodulation, supporting applications including interventional cardiology, structural heart repair, peripheral vascular intervention, electrophysiology and implantable medical devices. The company operates as a single reportable segment organised around these three product lines. Its largest customers are multinational medical-device original equipment manufacturers; Abbott Laboratories, Boston Scientific and Medtronic together accounted for approximately 49% of 2025 net sales.
For the fiscal year ended 31 December 2025, Integer Holdings Corporation reported consolidated net sales of $1.854 billion, an increase of 8% over fiscal year 2024, with fourth-quarter 2025 sales of $472 million, up 5% year over year, and adjusted diluted earnings-per-share growth of 21% for the full year, according to the company’s 19 February 2026 fourth-quarter and full-year results announcement. As of 31 December 2025, the company reported approximately 11,000 associates plus roughly 400 contingent workers across its global manufacturing and engineering operations.
On 24 October 2025, Integer Holdings Corporation completed a planned leadership transition: Payman Khales, previously the company’s Chief Operating Officer, assumed the roles of President and Chief Executive Officer, succeeding Joseph W. Dziedzic, who retired after eight years in the role and continues to serve as an advisor through 31 March 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
14
Directors and officers of Integer Holdings Corporation
Integer Holdings Corporation’s official corporate website, retrieved 16 September 2026, lists ten current executive officers: Payman Khales (President and Chief Executive Officer), Diron Smith (Executive Vice President and Chief Financial Officer), Kirk Thor (Executive Vice President and Chief Human Resources Officer), Tony Carr (Executive Vice President, Global Quality and Regulatory Affairs), Andrew Senn (President, Growth and Innovation), Jim Stephens (Executive Vice President, Special Projects), John Harris (President, Global Operations and Manufacturing Technology), Milo Metcalf (Executive Vice President, Global Operations), Lindsay Krause Blackwood (Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary), and Carol Russell (Vice President and Chief Information Officer). Kristen Stewart, CFA, is listed separately as Director of Investor Relations on the company’s investor relations contact page. Individual appointment dates are not itemised on the company website for most of these roles, other than the Chief Executive Officer transition described below. Nationality and country of residence are not publicly disclosed for any officer of this SEC-registered US company.
Recent officer changes
On 24 October 2025, Payman Khales assumed the roles of President and Chief Executive Officer, succeeding Joseph W. Dziedzic, who retired after eight years in the role and continues as an advisor through 31 March 2026 (source: company press release and SEC Form 8-K).
Data availability
Officer information is current only: the company’s website reflects its present executive roster but does not publish a historical record of former officers or exact appointment dates for most positions. Two individuals associated with certain roles in third-party company data tracked on this profile, including a previously reported Executive Vice President of Global Quality and Regulatory Affairs and a previously reported Vice President, Corporate Controller and Principal Accounting Officer, could not be confirmed as current officers against the company’s official leadership listing as of September 2026; status for these individuals is not disclosed. The Global Quality and Regulatory Affairs role is currently held by Tony Carr per the official company website.
Sources
Integer Holdings Corporation, official leadership page, https://www.integer.net/company/our-leadership/default.aspx (retrieved 16 September 2026); Integer Holdings Corporation investor relations contacts, https://investor.integer.net/investor-resources/investor-contacts/default.aspx (retrieved 16 September 2026); Integer Holdings Corporation press release, “Payman Khales Assumes Role as Integer President and CEO,” 24 October 2025, https://investor.integer.net/news-events/press-releases/news-details/2025/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO/default.aspx; SEC Form 8-K, CIK 0001114483, October 2025.
Registry feed — rows exactly as filed with Delaware Division of Corporations, including entries the profile above does not cover.
Group Structure
Group structure of Integer Holdings Corporation
Integer Holdings Corporation is a publicly traded parent company and is not itself a subsidiary of another entity; no controlling parent was identified in SEC filings. Per Exhibit 21.1 to its Form 10-K for the fiscal year ended 31 December 2025 (filed with the SEC 23 February 2026), the company has 31 verified direct and indirect subsidiaries spanning the United States and ten other jurisdictions, including Ireland, Switzerland, Mexico, the Netherlands, Malaysia, China, Germany, Costa Rica, Uruguay and Israel. The structure reflects the company’s acquisition history, including its 2015 merger with Lake Region Medical, which preceded the company’s 2016 renaming from Greatbatch, Inc. to Integer Holdings Corporation, and its 2018 acquisition of Accellent. Exhibit 21.1 does not disclose ownership percentages for individual subsidiaries.
Verified corporate relationships
Subsidiaries confirmed in Exhibit 21.1 of the FY2025 Form 10-K (ownership percentage not disclosed in the exhibit) include: Accellent LLC (Colorado); Greatbatch LLC (Delaware); Greatbatch Ltd., d/b/a Greatbatch Medical (New York); Greatbatch Medical SA (Switzerland); Greatbatch Medical, S. de R.L. de C.V. (Mexico); Greatbatch MCSO, S. de R.L. de C.V. (Mexico); Greatbatch Netherlands B.V. (Netherlands); Lake Region Medical, Inc. (Maryland); Lake Region Manufacturing, Inc. (Minnesota); Lake Region Medical Limited (Ireland); Lake Region Medical Holdings Limited (Ireland); Lake Region Medical Sdn. Bhd. (Malaysia); Lake (Shanghai) Medical Device Trading Co., Ltd. (China); Oscor Inc. (Florida); Oscor Caribe LLC (Florida); Oscor Europe GmbH (Germany); Pulse Technologies, Inc. (Pennsylvania); Proxy Biomedical Ltd. (Ireland); Aran Biomedical Teoranta (Ireland); Brivant Limited, d/b/a Lake Region Medical (Ireland); Connemara Biomedical Holdings Teo. (Ireland); Centro de Construccion de Cardioestimuladores del Uruguay SA (Uruguay); Venusa, Ltd (New York); Venusa de Mexico, S. de R.L. de C.V. (Mexico); Integer N2 Surface Technologies LLC, Integer Precision Technologies, LLC, Integer Hydrophilic Technologies LLC, Integer VSi Technologies, LLC and CPE 1, LLC (all Delaware); Integer EBDO SA (Switzerland); Integer SMI Ltd. (Israel); and Precision Coating, S.R.L. (Costa Rica).
Data availability
Group-structure disclosure is subsidiaries only: SEC Regulation S-K requires public companies to list significant subsidiaries but does not require disclosure of individual ownership percentages, and Integer Holdings Corporation’s status as the top entity in its own reporting structure is confirmed by the absence of any reported controlling shareholder or parent filer. Several additional entity names appear in third-party corporate-linkage data tracked on this profile but are not listed in the company’s current SEC Exhibit 21.1 and could not be independently verified as current subsidiaries; they are therefore omitted here as historical or unverified.
Sources
SEC EDGAR, Integer Holdings Corporation Form 10-K, Exhibit 21.1, “Subsidiaries of the Registrant,” filed 23 February 2026, https://www.sec.gov/Archives/edgar/data/1114483/000111448326000003/itgr-20251231ex211.htm (retrieved 16 September 2026).
Registry feed — rows exactly as filed with Delaware Division of Corporations, including entries the profile above does not cover.
INTEGER HOLDINGS CORPORATION
United States
Frequently asked questions
What does INTEGER HOLDINGS CORPORATION do?
Integer Holdings Corporation (Delaware, incorporated 6 January 1998, formerly Greatbatch, Inc.) is one of the world's largest medical device contract development and manufacturing organizations, headquartered in Plano, Texas, serving the Cardio & Vascular, Cardiac Rhythm Management and Neuromodulation markets for customers including Abbott Laboratories, Boston Scientific and Medtronic.
Who owns INTEGER HOLDINGS CORPORATION?
Per SEC Schedule 13G filings, Vanguard Capital Management (5.25%) and Vanguard Portfolio Management (6.03%) reported beneficial ownership as of 31 March 2026 following a January 2026 realignment of Vanguard's reporting structure; iShares (BlackRock) index funds also hold reported stakes. The full shareholder register is not public; major shareholders only.
Who is INTEGER HOLDINGS CORPORATION's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for INTEGER HOLDINGS CORPORATION is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
What is INTEGER HOLDINGS CORPORATION's company registration number?
INTEGER HOLDINGS CORPORATION's registration number is 2761902, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is INTEGER HOLDINGS CORPORATION still an active company?
INTEGER HOLDINGS CORPORATION's status on Delaware Division of Corporations is listed as active.
When was INTEGER HOLDINGS CORPORATION incorporated?
INTEGER HOLDINGS CORPORATION was incorporated on 6 January 1998, according to Delaware Division of Corporations.
What is INTEGER HOLDINGS CORPORATION's registered address?
The registered address on file for INTEGER HOLDINGS CORPORATION is United States.
What is INTEGER HOLDINGS CORPORATION's revenue?
Integer Holdings Corporation reported consolidated net sales of $1.854 billion for fiscal year 2025, up 8% from fiscal year 2024, with fourth-quarter 2025 sales of $472 million, per its 19 February 2026 results announcement.
Is INTEGER HOLDINGS CORPORATION listed on a stock exchange?
Integer Holdings Corporation's common stock trades on the New York Stock Exchange under the ticker symbol ITGR.
Who are the officers/directors of INTEGER HOLDINGS CORPORATION?
As of September 2026, Integer Holdings Corporation's officers include Payman Khales (President & CEO, since 24 October 2025), Diron Smith (EVP & CFO), Kirk Thor (EVP & Chief Human Resources Officer) and Tony Carr (EVP, Global Quality & Regulatory Affairs), among other named executives per the company's official leadership page.
Does INTEGER HOLDINGS CORPORATION have a parent company or subsidiaries?
Per Exhibit 21.1 of its FY2025 Form 10-K, Integer Holdings Corporation has 31 verified subsidiaries across the United States, Ireland, Switzerland, Mexico, the Netherlands, Malaysia, China, Germany, Costa Rica, Uruguay and Israel, reflecting its Greatbatch/Lake Region Medical/Accellent acquisition history; no parent company was identified.